MedPath

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Nocturnal Breathing Pattern in Lowlanders

Not Applicable
Completed
Conditions
Effect of High Altitude
Interventions
Other: Altitude exposure
Registration Number
NCT02730143
Lead Sponsor
University of Zurich
Brief Summary

Prospective interventional trial in lowlanders evaluating the effect of acute exposure, acclimatization and re-exposure of high altitude on nocturnal breathing pattern.

Detailed Description

Respiratory polygraphies will be performed in Santiago de Chile, 520 m, over the course of 3 days. Participants will then travel by commercial airline (5 h flight) and by bus (3 h ride) to the ALMA base camp located at 2900 m near San Pedro de Atacama, northern Chile. Participants will stay there for the next 7 nights and respiratory polygraphies will be performed on night 1 and 6. They will be spend the days (6-8 h daily) at the telescope station at 5050 m while undergoing physiological testing. Daily transports from 2900 to 5050 m will be by car (1 h ride, one way). After the first 8 day altitude sojourn participants will return to the Santiago area (520 m) for a 6 day recovery period.

A second altitude sojourn with an identical schedule as the one described above and a final low altitude stay of 3 days will follow.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • born, raised and currently living <800m
  • No overnight stay at altitudes >1500 m 4 weeks before the study
Read More
Exclusion Criteria
  • Previous altitude intolerance to altitude <3000 m
  • Pregnancy
  • Health impairment, which requires regular treatment
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Altitude exposureAltitude exposureAcute high altitude exposure followed by 8 day acclimatization and re-exposure after 6 days at low altitude
Primary Outcome Measures
NameTimeMethod
Mean nocturnal oxygen saturation measured by pulse oximetryfirst sojourn at 5050 m, night 1, 6; second sojourn at 5050 m, night 1, 6; low altitude sojourn at 520 m, night 1

Change in mean nocturnal oxygen saturation over the course of high altitude exposure during 2 sojourns at 5050 m compared to low altitude

Secondary Outcome Measures
NameTimeMethod
Acute mountain sickness measured by the Environmental Symptom questionnaire cerebral score (AMSc)first sojourn at 5050 m, day 2, 7; second sojourn at 5050 m, day 2,7; low altitude sojourn at 520 m, day 2

Incidence of acute mountain sickness (AMSc score \>= 0.7) over the course of high altitude exposure during 2 sojourns at 5050 m compared to low altitude

Oxygen desaturation index measured by respiratory polygraphyfirst sojourn at 5050 m, night 1, 6; second sojourn at 5050 m, night 1, 6; low altitude sojourn at 520 m, night 1

Change in oxygen desaturation index over the course of high altitude exposure during 2 sojourns at 5050 m compared to low altitude

Apnea-/hypopnea index measured by respiratory polygraphyfirst sojourn at 5050 m, night 1, 6; second sojourn at 5050 m, night 1, 6; low altitude sojourn at 520 m, night 1

Change in apnea-/hypopnea index over the course of high altitude exposure during 2 sojourns at 5050 m compared to low altitude

Trial Locations

Locations (1)

University of Zurich

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath